Across TCGA pan-cancer cohorts, VN1R13P RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated VN1R13P data layer.
The strongest signal is observed in thyroid carcinoma (THCA), where higher VN1R13P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated VN1R13P expression acts as an unfavorable survival marker, although some lineages such as LUAD and HNSC show a favorable association.
THCA, OV, and BLCA are the cancer types where VN1R13P RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.